Envestnet Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.91M | Buy |
314,273
+78,958
| +34% | +$1.06M | ﹤0.01% | 2512 |
|
|
2025
Q4 | $2.96M | Buy |
235,315
+74,705
| +47% | +$855K | ﹤0.01% | 2541 |
|
|
2025
Q3 | $1.61M | Buy |
+160,610
| New | +$1.44M | ﹤0.01% | 3022 |
|
|
2024
Q2 | – | Sell |
-41,050
| Closed | -$249K | – | 4167 |
|
|
2024
Q1 | $249K | Sell |
41,050
-159
| -0.4% | -$897 | ﹤0.01% | 3828 |
|
|
2023
Q4 | $250K | Buy |
41,209
+12,723
| +45% | +$56.7K | ﹤0.01% | 3713 |
|
|
2023
Q3 | $120K | Buy |
+28,486
| New | +$106K | ﹤0.01% | 3845 |
|
|
2022
Q3 | – | Sell |
-20,295
| Closed | -$65K | – | 3900 |
|
|
2022
Q2 | $65K | Sell |
20,295
-7,453
| -27% | -$27K | ﹤0.01% | 3794 |
|
|
2022
Q1 | $116K | Buy |
27,748
+278
| +1% | +$1.23K | ﹤0.01% | 3784 |
|
|
2021
Q4 | $132K | Buy |
27,470
+16,790
| +157% | +$83.7K | ﹤0.01% | 3732 |
|
|
2021
Q3 | $57K | Sell |
10,680
-746
| -7% | -$3.76K | ﹤0.01% | 3630 |
|
|
2021
Q2 | $59K | Buy |
11,426
+1,042
| +10% | +$5.92K | ﹤0.01% | 3595 |
|
|
2021
Q1 | $70K | Sell |
10,384
-15
| -0.1% | -$83 | ﹤0.01% | 3440 |
|
|
2020
Q4 | $48K | Sell |
10,399
-872
| -8% | -$3.86K | ﹤0.01% | 3229 |
|
|
2020
Q3 | $44K | Buy |
+11,271
| New | +$48.2K | ﹤0.01% | 3064 |
|
|
2019
Q2 | – | Sell |
-55,268
| Closed | -$783K | – | 3024 |
|
|
2019
Q1 | $783K | Buy |
55,268
+8,679
| +19% | +$115K | ﹤0.01% | 2043 |
|
|
2018
Q4 | $630K | Buy |
+46,589
| New | +$840K | ﹤0.01% | 2011 |
|
|
2018
Q3 | – | Sell |
-9,177
| Closed | -$151K | – | 1297 |
|
|
2018
Q2 | $151K | Buy |
+9,177
| New | +$161K | ﹤0.01% | 1803 |
|
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
